|
Sleep Apnea in Patients With MGUS and MM
RECRUITINGSponsored by Michael Tomasson
Actively Recruiting
SponsorMichael Tomasson
Started2019-05-23
Est. completion2030-05-23
Eligibility
Age18 Years – 99 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT04114084
Summary
This study involves patients with plasma cell dyscrasia including monoclonal gammopathy of undetermined significance (MGUS) or multiple myeloma (MM), with and without sleep apnea, who are providing bone marrow specimens. Specimens will be obtained at the time that patients undergo a standard-of-care procedure in order to minimize discomfort and reduce any risk.
Eligibility
Age: 18 Years – 99 YearsHealthy volunteers accepted
Patients diagnosed with MGUS or MM who will be receiving a bone marrow biopsy as part of their standard of care are eligible to participate in this study
Conditions3
CancerMonoclonal Gammopathy of Undetermined SignificanceMultiple Myeloma
Locations1 site
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorMichael Tomasson
Started2019-05-23
Est. completion2030-05-23
Eligibility
Age18 Years – 99 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT04114084